Skip to main content

COLUMBUS MCKINNON CORP

For the period ended Mar 31, 2024. Filed May 29, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed May 29, 2024

CMCO$20.32+3.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Year ended March 31,
202420232022
Operating activities: · (In thousands)
Net income$46,625$48,429$29,660
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization45,94541,94741,924
Deferred income taxes and related valuation allowance(15,285)(300)(1,969)
Net loss (gain) on sale of real estate, investments and other(1,431)(54)136
Stock-based compensation12,03910,42511,246
Amortization of deferred financing costs2,3491,7211,703
Loss (gain) on hedging instruments(1,366)(438)853
Cost of debt refinancing——14,803
Cost of debt repricing958——
Loss on retirement of fixed asset—175—
Non-cash pension settlement expense (See Note 13)4,984——
Gain on sale of building (See Note 3)—(232)(375)
Non-cash lease expense9,7357,8677,945
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:
Trade accounts receivable(14,428)(4,858)(18,988)
Inventories(1,314)(9,087)(40,201)
Prepaid expenses and other(8,555)6,667(47)
Other assets537(123)25
Trade accounts payable4,748(13,964)12,681
Accrued liabilities(9,583)9,150696
Non-current liabilities(8,760)(13,689)(11,211)
Net cash provided by (used for) operating activities67,19883,63648,881
Investing activities:
Proceeds from sales of marketable securities3,5263,6514,434
Purchases of marketable securities(4,076)(4,021)(7,130)
Capital expenditures(24,813)(12,632)(13,104)
Proceeds from sale of building, net of transaction costs—373461
Proceeds from insurance reimbursement——482
Dividend received from equity method investment144313324
Purchase of businesses, net of cash acquired (See Note 3)(108,145)(1,616)(539,778)
Net cash provided by (used for) investing activities(133,364)(13,932)(554,311)
Financing activities:
Proceeds from issuance of common stock1,6007132,655
Fees paid for debt repricing(958)——
Purchases of treasury stock—(1,001)—
Repayment of debt(60,604)(40,550)(477,846)
Fees paid for borrowing on long-term debt(2,859)——
Proceeds from issuance of long-term debt120,000—725,000
Proceeds from equity offering——207,000
Fees related to debt and equity offering——(26,184)
Cash inflows from hedging activities24,05724,49519,417
Cash outflows from hedging activities(22,687)(24,221)(20,206)
Payment of dividends(8,044)(8,008)(6,562)
Other(2,304)(1,415)(2,574)
Net cash provided by (used for) financing activities48,201(49,987)420,700
Effect of exchange rate changes on cash(1,085)(1,931)(2,007)
Net change in cash and cash equivalents(19,050)17,786(86,737)
Cash, cash equivalents, and restricted cash at beginning of year133,426115,640202,377
Cash, cash equivalents, and restricted cash at end of year$114,376$133,426$115,640
Supplementary cash flows data:
Interest paid$34,983$26,089$18,823
Income taxes paid, net of refunds$28,369$22,032$9,767
Property, plant and equipment purchases included in trade accounts payable$690$624$329
Restricted cash presented in Other assets$250$250$250
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.